Journals

The FDA has now approved zongertinib, a tyrosine kinase inhibitor, for the treatment of adult patients with unresectable or metastatic…

BATURA trial results showed that as-needed use of an ICS-SABA combination may help control symptoms and mitigate exacerbation…

Explore the latest issue of AMJ Oncology, featuring expert insights from American Society of Clinical Oncology (ASCO) 2025, new research…

New findings explore the efficacy and safety of deucravacitinib in moderate-to-severe plaque psoriasis, including scalp outcomes and…

The latest issue of AMJ Respiratory centers on evidence-based approaches that directly impact patient outcomes. From lung transplant…

New findings from an extended analysis of the CheckMate 274 trial offer fresh insight into post-surgical treatment for high-risk…

This issue features expert commentary from the 2025 American Academy of Neurology (AAN) Annual Meeting, high-impact original articles…

Prostate cancer progression remains a major challenge in metastatic hormone-sensitive prostate cancer, despite therapeutic advances, and…